Zobrazeno 1 - 10
of 224
pro vyhledávání: '"Qinqin Xu"'
Autor:
Haoyue Qin, Huan Yan, Yangqian Chen, Qinqin Xu, Zhe Huang, Wenjuan Jiang, Zhan Wang, Li Deng, Xing Zhang, Lin Zhang, Nong Yang, Liang Zeng, Yongchang Zhang
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Limited data exists on the efficacy of immune checkpoint inhibitor (ICI) combinations in non-small-cell lung cancer (NSCLC) with uncommon driver alterations in genes such as ERBB2, BRAF, RET, and MET. This study retrospectively as
Externí odkaz:
https://doaj.org/article/c41750fbe4b64c9eb1c84566a8bc7ed4
Publikováno v:
Thoracic Cancer, Vol 15, Iss 8, Pp 667-671 (2024)
Abstract Pericardial synovial sarcomas (PSS) have a low incidence rate and are highly invasive with a dismal prognosis. Standard treatment includes surgery, radiotherapy and chemotherapy but with limited response. Here, we report the case of a 15‐y
Externí odkaz:
https://doaj.org/article/9e4e6f83c7f84c0991ae9dbb746f7046
Autor:
Qinqin Xu, Siliang Shu
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract The Yellow River Basin is an important ecological barrier and economic core area in China, with problems such as fragile ecological environment and ecosystem degradation, and promoting industrial ecological transformation in resource cities
Externí odkaz:
https://doaj.org/article/5c81343caebb403d95be7ba1f60d08ea
Autor:
Zhe Huang, Fang Wu, Qinqin Xu, Lianxi Song, Xiangyu Zhang, Zhan Wang, Li Deng, Yongchang Zhang, Liang Zeng, Nong Yang, Xiangxiang Pan, Peifang Wei
Publikováno v:
Chinese Medical Journal, Vol 136, Iss 12, Pp 1422-1429 (2023)
Abstract. Background:. Immune checkpoint inhibitors (ICIs) are increasingly used as first-line therapy for patients with advanced non-small cell lung cancer (NSCLC) harboring no actionable mutations; however, data on their efficacy among patients pre
Externí odkaz:
https://doaj.org/article/4ea31d5c69f14b71beee25a67bb7fe8f
Autor:
Lianxi Song, Fei Zhou, Tian Xu, Liang Zeng, Qing Xia, Zhan Wang, Li Deng, Yizhi Li, Haoyue Qin, Huan Yan, Zhe Huang, Jinye Mi, Qinqin Xu, Nong Yang, Caicun Zhou, Yongchang Zhang
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Immune checkpoint inhibitors (ICI)-based combination strategies have improved the survival outcomes in advanced non-small cell lung cancers; however, data regarding their efficacy remains limited for uncommon histological types, i
Externí odkaz:
https://doaj.org/article/4d40d9e1976d40de87384eafa603e720
Publikováno v:
Frontiers in Environmental Science, Vol 11 (2023)
Dam construction interfered with the original environment of the river system and greatly affected the geochemical behaviors of trace metals. Thus, a set of toxic metals of Cr, Ni, Cu, Zn, As, Cd, Pb and Hg in soil/sediment of the Three Gorges Reserv
Externí odkaz:
https://doaj.org/article/6cd9db3620cc4eb5a3b9967cf89b0c68
Publikováno v:
Journal of Modern Power Systems and Clean Energy, Vol 11, Iss 4, Pp 1282-1293 (2023)
With the extensive penetration of distributed renewable energy and self-interested prosumers, the emerging power market tends to enable user autonomy by bottom-up control and distributed coordination. This paper is devoted to solving the specific pro
Externí odkaz:
https://doaj.org/article/3c5a90a2707542ef8367e0fb38a8ddfd
Publikováno v:
Molecular Medicine, Vol 28, Iss 1, Pp 1-14 (2022)
Abstract Background The T helper 17 (Th17)/T regulatory (Treg) cell imbalance is involved in the course of obesity and type 2 diabetes mellitus (T2DM). In the current study, the exact role of glucagon-like peptide-1 receptor agonist (GLP-1RA) exenati
Externí odkaz:
https://doaj.org/article/a0094b01db0c4992be649d9c9fafc438
Autor:
Lianxi Song, Liang Zeng, Huan Yan, Qinqin Xu, Qing Xia, Jian Lei, Xiaoyan Chen, Xiaoping Hu, Zhan Wang, Hong Liu, Nong Yang, Yongchang Zhang
Publikováno v:
Communications Medicine, Vol 2, Iss 1, Pp 1-9 (2022)
Song, Zeng, Yan et al. validate the E1L3N monoclonal antibody for the detection of PD-L1 in NSCLC samples. The authors show that PD-L1 scores assessed with E1L3N are concordant with the 22C3 assay and are associated with response to first-line pembro
Externí odkaz:
https://doaj.org/article/020703bde7a244a4bb74e348b54692ad
Autor:
Yongchang Zhang, Lianxi Song, Liang Zeng, Yi Xiong, Li Liu, Chunhua Zhou, Haiyan Yang, Zhan Wang, Qing Xia, Wenjuan Jiang, Qinqin Xu, Nong Yang
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-13 (2022)
Highlights • Survival outcomes of patients with NSCLC without targetable mutations remain depressing. • Sintilimab plus docetaxel as second-line therapy improves progression-free survival outcomes. • Sintilimab plus docetaxel is safe and well-t
Externí odkaz:
https://doaj.org/article/d76394190b1d4ef0bd44e66f043efd2c